To The Moon
Home
News
TigerAI
Log In
Sign Up
NeM0ooo
+Follow
Posts · 0
Posts · 0
Following · 0
Following · 0
Followers · 0
Followers · 0
NeM0ooo
NeM0ooo
·
2022-01-24
Like
Sorry, this post has been deleted
看
3.76K
回复
Comment
点赞
Like
编组 21备份 2
Share
Report
NeM0ooo
NeM0ooo
·
2022-01-22
[Spurting]
3 Top Mid-Cap Stocks That Are Wildly Undervalued Right Now
These small-ish companies look like deals given their expected growth rates.
3 Top Mid-Cap Stocks That Are Wildly Undervalued Right Now
看
3.00K
回复
Comment
点赞
3
编组 21备份 2
Share
Report
NeM0ooo
NeM0ooo
·
2022-01-21
Like
Sorry, this post has been deleted
看
3.94K
回复
Comment
点赞
3
编组 21备份 2
Share
Report
NeM0ooo
NeM0ooo
·
2022-01-20
Like
US STOCKS-Wall Street Sell-Off Deepens, Nasdaq Confirms Correction
* Nasdaq now down 10.7% from Nov 19 record close* BofA, Morgan Stanley wrap up bank earnings on upbe
US STOCKS-Wall Street Sell-Off Deepens, Nasdaq Confirms Correction
看
2.94K
回复
Comment
点赞
5
编组 21备份 2
Share
Report
NeM0ooo
NeM0ooo
·
2022-01-17
Like
Sorry, this post has been deleted
看
3.97K
回复
Comment
点赞
5
编组 21备份 2
Share
Report
NeM0ooo
NeM0ooo
·
2022-01-17
Like
Sorry, this post has been deleted
看
4.54K
回复
Comment
点赞
4
编组 21备份 2
Share
Report
NeM0ooo
NeM0ooo
·
2022-01-15
Like
Morgan Stanley Promotes Biggest Class of Managing Directors Since 2012
While efforts to hire and retain workers pick up across Wall Street, Morgan Stanley(NYSE:MS)names 19
Morgan Stanley Promotes Biggest Class of Managing Directors Since 2012
看
4.14K
回复
Comment
点赞
4
编组 21备份 2
Share
Report
NeM0ooo
NeM0ooo
·
2022-01-14
Like
J&J booster 85% effective against hospitalisation by Omicron for 1-2 months -S.African study
JOHANNESBURG, Jan 14 (Reuters) - A Johnson and Johnson COVID-19 vaccine booster shot is 85% effectiv
J&J booster 85% effective against hospitalisation by Omicron for 1-2 months -S.African study
看
4.18K
回复
Comment
点赞
1
编组 21备份 2
Share
Report
NeM0ooo
NeM0ooo
·
2022-01-13
Like
Novavax Stock Still Has A Solid Chance
The Covid-19 pandemic has worked in the favor of pharmaceutical companies. Many have become hot pick
Novavax Stock Still Has A Solid Chance
看
2.51K
回复
Comment
点赞
3
编组 21备份 2
Share
Report
NeM0ooo
NeM0ooo
·
2022-01-12
Like
Sorry, this post has been deleted
看
3.04K
回复
Comment
点赞
5
编组 21备份 2
Share
Report
Load more
Most Discussed
{"i18n":{"language":"en_US"},"isCurrentUser":false,"userPageInfo":{"id":"4091976027440070","uuid":"4091976027440070","gmtCreate":1628872964574,"gmtModify":1629964817147,"name":"NeM0ooo","pinyin":"nem0ooo","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/fc945b6e362666c4cb11d3c9b09018e8","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":10,"headSize":271,"tweetSize":0,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.09.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.05.14","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":9007445601,"gmtCreate":1642991056019,"gmtModify":1676533762891,"author":{"id":"4091976027440070","authorId":"4091976027440070","name":"NeM0ooo","avatar":"https://static.tigerbbs.com/fc945b6e362666c4cb11d3c9b09018e8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091976027440070","idStr":"4091976027440070"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9007445601","repostId":"2205027095","repostType":4,"isVote":1,"tweetType":1,"viewCount":3756,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9007600222,"gmtCreate":1642850964033,"gmtModify":1676533752746,"author":{"id":"4091976027440070","authorId":"4091976027440070","name":"NeM0ooo","avatar":"https://static.tigerbbs.com/fc945b6e362666c4cb11d3c9b09018e8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091976027440070","idStr":"4091976027440070"},"themes":[],"htmlText":"[Spurting] ","listText":"[Spurting] ","text":"[Spurting]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9007600222","repostId":"2205042784","repostType":4,"repost":{"id":"2205042784","kind":"highlight","pubTimestamp":1642807833,"share":"https://ttm.financial/m/news/2205042784?lang=en_US&edition=fundamental","pubTime":"2022-01-22 07:30","market":"us","language":"en","title":"3 Top Mid-Cap Stocks That Are Wildly Undervalued Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2205042784","media":"Motley Fool","summary":"These small-ish companies look like deals given their expected growth rates.","content":"<div>\n<p>While the market overall had a pretty good year in 2021 (the S&P 500, slanted toward large-cap stocks, was up 27%), the performance of small- and mid-cap stocks was mixed. Some tech stocks suffered ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/21/mid-cap-stocks-wildly-undervalued-magnite-redfin/\">Source Link</a>\n\n</div>\n","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Top Mid-Cap Stocks That Are Wildly Undervalued Right Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Top Mid-Cap Stocks That Are Wildly Undervalued Right Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-22 07:30 GMT+8 <a href=https://www.fool.com/investing/2022/01/21/mid-cap-stocks-wildly-undervalued-magnite-redfin/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>While the market overall had a pretty good year in 2021 (the S&P 500, slanted toward large-cap stocks, was up 27%), the performance of small- and mid-cap stocks was mixed. Some tech stocks suffered ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/21/mid-cap-stocks-wildly-undervalued-magnite-redfin/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4146":"鞋类","RDFN":"Redfin Corp","BK4009":"广告","CROX":"卡骆驰","BK4079":"房地产服务","MGNI":"Magnite, Inc.","BK4548":"巴美列捷福持仓"},"source_url":"https://www.fool.com/investing/2022/01/21/mid-cap-stocks-wildly-undervalued-magnite-redfin/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2205042784","content_text":"While the market overall had a pretty good year in 2021 (the S&P 500, slanted toward large-cap stocks, was up 27%), the performance of small- and mid-cap stocks was mixed. Some tech stocks suffered sharp pullbacks after skyrocketing earlier on in the pandemic, even though the businesses themselves continue to grow at a healthy pace.After a wild year, Magnite (NASDAQ:MGNI), Redfin (NASDAQ:RDFN), and Crocs (NASDAQ:CROX) look way undervalued right now based on their future potential. Here's why these three mid-cap stocks are worth a closer look.Image source: Getty Images.1. Magnite: Steadily expanding with streaming TVMagnite stock hasn't been able to catch a break since quickly doubling in value in the first couple months of 2021. Share prices are down 77% from their all-time high posted nearly a year ago, valuing the software company at a mere $2.4 billion (as measured by enterprise value).In hindsight, Magnite was way overpriced 12 months ago. Over-optimism had set in, driven by the company's fast-growing platform, which helps video publishers sell advertising slots. Connected TV (CTV) is taking over the at-home entertainment space as a myriad of new streaming services pick up subscribers and traditional video moves to an internet-delivered format. Magnite is the largest independent CTV software company. Hundreds of publishers rely on it to automate the selling of ads and maximize value for their content.But a company that expects to grow sales at an average of 25% per year in each of the next five years didn't deserve to trade at a trailing 12-month sales multiple of over 20 (which is where Magnite was early in 2021). Now shares trade for a mere 4.5 times trailing 12-month sales, which seems incredibly cheap considering this is a highly profitable and growing business. Adjusted EBITDA profit margin was 35% in Q3 2021, and management expects it to be at over 40% in the coming years.Of course, the digital ad software space is highly competitive, and Magnite has a lot of debt due to a couple of acquisitions ($719 million as of the end of September 2021). But Magnite generates plenty of cash to service its debt, and is poised to continue expanding with the CTV industry in the coming years. Even management thinks its stock is a pretty good deal right now. It announced a $50 million share repurchase program in December. I like this CTV ad stock at these levels too.2. Redfin: A full-service tech-powered brokerage firmThe real estate brokerage business is a cyclical one, and Redfin's stock has been suffering on fears of a too-hot residential housing market. Supply of homes available for sale has been thin during the pandemic as Americans relocate en masse, and now with interest rates set to rise this year, there's another reason to worry. Redfin stock is down nearly 60% in the last year, giving it an enterprise value of $4.2 billion.Redfin won't be an appropriate stock for every investor. The company is spending heavily to maximize sales growth right now, and generated negative free cash flow of $429 million over the last 12-month stretch. But at just 2.2 times trailing 12-month sales, a substantial amount of negativity has been priced in at this point.After all, Redfin is still steadily winning market share (1.16% of U.S. existing home value in Q3 2021, compared to 1.04% the year prior). It's still expanding its services into new cities, acquired an online rental listing site last spring, and recently announced it's purchasing Bay Equity Home Loans to expand on its mortgage services. Redfin has a full-service technology stack to help home buyers and sellers, and it has lots of potential avenues for growth ahead -- regardless of where the real estate market goes next.Management had said to expect year-over-year revenue growth of as much as 148% in Q4 2021, a torrid pace that is unlikely to continue in the new year. Nevertheless, with shares depressed in value and Redfin still making progress in the residential real estate market, now looks like a pretty good time to nibble on this tech stock.3. Crocs: Comfort and utility for the winCrocs sales have been soaring during the pandemic, bucking the trend of overall declines elsewhere in the apparel and clothing department. In 2021 alone, the company stated it's expecting record full-year sales topping $2.3 billion, growth of 67% over 2020. In spite of this, share prices have dropped a third in value in recent months. Crocs has an enterprise value of $7.2 billion.Comfort and utility are in vogue as the pandemic reshapes consumer behavior. As a result of this and a push into new markets in Asia, Crocs thinks it will remain a fast-growing shoe company for years. Management's goal is to reach $5 billion in annual sales by 2026. 2022 is off to a good start working toward that milestone. Excluding the recent acquisition of small casual shoe brand Hey Dude, Crocs expects sales growth to exceed 20%, all while maintaining an adjusted operating profit margin of about 28%. That makes this quirky shoe business one of the most profitable in the industry.When Crocs announced it was acquiring Hey Dude last month for $2.5 billion, I was initially skeptical. However, it was revealed the small casual brand should bring in as much as $750 million in sales in 2022, with an adjusted operating margin of 26%. Plugged into Crocs' existing distribution channels, this could be a new growth lever for Crocs in the years ahead.Considering Crocs' 2022 outlook, shares currently trade for just 7 times adjusted operating income (assuming Crocs generates that 28% margin, and Hey Dude 26%). Of course, Crocs will need to prove it's the real deal and deliver the goods. But if it does, this looks like one overlooked cheap shoe stock right now.","news_type":1,"symbols_score_info":{"CTV":1,"MGNI":1,"CROX":1,"RDFN":1}},"isVote":1,"tweetType":1,"viewCount":2995,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9007302944,"gmtCreate":1642762186624,"gmtModify":1676533743795,"author":{"id":"4091976027440070","authorId":"4091976027440070","name":"NeM0ooo","avatar":"https://static.tigerbbs.com/fc945b6e362666c4cb11d3c9b09018e8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091976027440070","idStr":"4091976027440070"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9007302944","repostId":"1152667345","repostType":4,"isVote":1,"tweetType":1,"viewCount":3940,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9004469290,"gmtCreate":1642663143859,"gmtModify":1676533733433,"author":{"id":"4091976027440070","authorId":"4091976027440070","name":"NeM0ooo","avatar":"https://static.tigerbbs.com/fc945b6e362666c4cb11d3c9b09018e8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091976027440070","idStr":"4091976027440070"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9004469290","repostId":"2204320050","repostType":4,"repost":{"id":"2204320050","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1642629300,"share":"https://ttm.financial/m/news/2204320050?lang=en_US&edition=fundamental","pubTime":"2022-01-20 05:55","market":"us","language":"en","title":"US STOCKS-Wall Street Sell-Off Deepens, Nasdaq Confirms Correction","url":"https://stock-news.laohu8.com/highlight/detail?id=2204320050","media":"Reuters","summary":"* Nasdaq now down 10.7% from Nov 19 record close* BofA, Morgan Stanley wrap up bank earnings on upbe","content":"<html><head></head><body><p>* Nasdaq now down 10.7% from Nov 19 record close</p><p>* BofA, <a href=\"https://laohu8.com/S/MSTLW\">Morgan Stanley</a> wrap up bank earnings on upbeat note</p><p>* Procter & Gamble gains after raising outlook</p><p>* Indexes down: Dow 0.96%, S&P 0.97%, Nasdaq 1.15%</p><p>Jan 19 (Reuters) - Wall Street's main indexes ended sharply lower on Wednesday, with the tech-heavy Nasdaq confirming it was in a correction, after a diverse set of corporate earnings and as investors continued to worry about higher U.S. Treasury yields and the Federal Reserve tightening monetary policy.</p><p>The Nasdaq ended down 10.7% from its Nov. 19 closing record high, as stocks sold off into the market close. A correction is confirmed when an index closes 10% or more below its record closing level.</p><p>The Nasdaq's last correction was in early 2021, when the tech-heavy index fell more than 10% from Feb. 12 to March 8. It was the fourth time in the two years</p><p>since the coronavirus pandemic shook global markets that the index has found itself in a correction.</p><p>On Wednesday, Apple shares fell 2.1%, weighing most on the Nasdaq, while declines in Tesla and Amazon also dragged on the index.</p><p>Stocks have gotten off to a rocky start in 2022, as a fast rise in Treasury yields amid concerns the Fed will become aggressive in controlling inflation has particularly hit tech and growth shares. The benchmark S&P 500 is down about 5% so far this year.</p><p>“Any beginning of tightening often results in significant volatility and I think there is always that risk that there is a policy error and it ends the economic cycle," said Kristina Hooper, chief global market strategist at Invesco. "So we just have a lot of apprehension.”</p><p>The Dow Jones Industrial Average fell 339.82 points, or 0.96%, to 35,028.65, the S&P 500 lost 44.35 points, or 0.97%, to 4,532.76 and the Nasdaq Composite dropped 166.64 points, or 1.15%, to 14,340.26.</p><p>Consumer discretionary fell most among S&P 500 sectors, dropping 1.8%, while financials dropped about 1.7% and technology slid 1.4%.</p><p>The small-cap Russell 2000 fell 1.6%.</p><p>Stocks had tumbled on Tuesday, with the Nasdaq falling 2.6%, after weak results from Goldman Sachs and a spike in Treasury yields. U.S. Treasury yields eased on Wednesday from two-year highs.</p><p>Investors are looking to next week's Fed policy meeting for more clarity on central bankers' plans to rein in inflation. Data last week showed U.S. consumer prices increased solidly in December, culminating in the largest annual rise in inflation in nearly four decades.</p><p>"There's a fair amount of anxiety in terms of how the next three to six months are going to play out with a rate-hike cycle set to start likely in March," said Michael James, managing director of equity trading at Wedbush Securities in Los Angeles.</p><p>In company news, shares of Procter & Gamble rose 3.4% after the consumer goods company bumped up its annual sales forecast.</p><p>$Bank of America Corp(BAC-N)$ reported a better-than-expected 30% jump in quarterly profit, while Morgan Stanley also reported fourth-quarter profit which beat market expectations, following uneven results from other banks. Bank of America shares rose 0.4%, while Morgan Stanley shares gained 1.8%.</p><p>Declining issues outnumbered advancing ones on the NYSE by a 2.06-to-1 ratio; on Nasdaq, a 2.09-to-1 ratio favored decliners.</p><p>The S&P 500 posted 13 new 52-week highs and seven new lows; the Nasdaq Composite recorded 23 new highs and 630 new lows.</p><p>About 11.4 billion shares changed hands in U.S. exchanges, compared with the 10 billion daily average over the last 20 sessions.</p><p>Nasdaq confirms fourth correction since pandemic hit.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US STOCKS-Wall Street Sell-Off Deepens, Nasdaq Confirms Correction</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS STOCKS-Wall Street Sell-Off Deepens, Nasdaq Confirms Correction\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2022-01-20 05:55</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>* Nasdaq now down 10.7% from Nov 19 record close</p><p>* BofA, <a href=\"https://laohu8.com/S/MSTLW\">Morgan Stanley</a> wrap up bank earnings on upbeat note</p><p>* Procter & Gamble gains after raising outlook</p><p>* Indexes down: Dow 0.96%, S&P 0.97%, Nasdaq 1.15%</p><p>Jan 19 (Reuters) - Wall Street's main indexes ended sharply lower on Wednesday, with the tech-heavy Nasdaq confirming it was in a correction, after a diverse set of corporate earnings and as investors continued to worry about higher U.S. Treasury yields and the Federal Reserve tightening monetary policy.</p><p>The Nasdaq ended down 10.7% from its Nov. 19 closing record high, as stocks sold off into the market close. A correction is confirmed when an index closes 10% or more below its record closing level.</p><p>The Nasdaq's last correction was in early 2021, when the tech-heavy index fell more than 10% from Feb. 12 to March 8. It was the fourth time in the two years</p><p>since the coronavirus pandemic shook global markets that the index has found itself in a correction.</p><p>On Wednesday, Apple shares fell 2.1%, weighing most on the Nasdaq, while declines in Tesla and Amazon also dragged on the index.</p><p>Stocks have gotten off to a rocky start in 2022, as a fast rise in Treasury yields amid concerns the Fed will become aggressive in controlling inflation has particularly hit tech and growth shares. The benchmark S&P 500 is down about 5% so far this year.</p><p>“Any beginning of tightening often results in significant volatility and I think there is always that risk that there is a policy error and it ends the economic cycle," said Kristina Hooper, chief global market strategist at Invesco. "So we just have a lot of apprehension.”</p><p>The Dow Jones Industrial Average fell 339.82 points, or 0.96%, to 35,028.65, the S&P 500 lost 44.35 points, or 0.97%, to 4,532.76 and the Nasdaq Composite dropped 166.64 points, or 1.15%, to 14,340.26.</p><p>Consumer discretionary fell most among S&P 500 sectors, dropping 1.8%, while financials dropped about 1.7% and technology slid 1.4%.</p><p>The small-cap Russell 2000 fell 1.6%.</p><p>Stocks had tumbled on Tuesday, with the Nasdaq falling 2.6%, after weak results from Goldman Sachs and a spike in Treasury yields. U.S. Treasury yields eased on Wednesday from two-year highs.</p><p>Investors are looking to next week's Fed policy meeting for more clarity on central bankers' plans to rein in inflation. Data last week showed U.S. consumer prices increased solidly in December, culminating in the largest annual rise in inflation in nearly four decades.</p><p>"There's a fair amount of anxiety in terms of how the next three to six months are going to play out with a rate-hike cycle set to start likely in March," said Michael James, managing director of equity trading at Wedbush Securities in Los Angeles.</p><p>In company news, shares of Procter & Gamble rose 3.4% after the consumer goods company bumped up its annual sales forecast.</p><p>$Bank of America Corp(BAC-N)$ reported a better-than-expected 30% jump in quarterly profit, while Morgan Stanley also reported fourth-quarter profit which beat market expectations, following uneven results from other banks. Bank of America shares rose 0.4%, while Morgan Stanley shares gained 1.8%.</p><p>Declining issues outnumbered advancing ones on the NYSE by a 2.06-to-1 ratio; on Nasdaq, a 2.09-to-1 ratio favored decliners.</p><p>The S&P 500 posted 13 new 52-week highs and seven new lows; the Nasdaq Composite recorded 23 new highs and 630 new lows.</p><p>About 11.4 billion shares changed hands in U.S. exchanges, compared with the 10 billion daily average over the last 20 sessions.</p><p>Nasdaq confirms fourth correction since pandemic hit.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index",".DJI":"道琼斯"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2204320050","content_text":"* Nasdaq now down 10.7% from Nov 19 record close* BofA, Morgan Stanley wrap up bank earnings on upbeat note* Procter & Gamble gains after raising outlook* Indexes down: Dow 0.96%, S&P 0.97%, Nasdaq 1.15%Jan 19 (Reuters) - Wall Street's main indexes ended sharply lower on Wednesday, with the tech-heavy Nasdaq confirming it was in a correction, after a diverse set of corporate earnings and as investors continued to worry about higher U.S. Treasury yields and the Federal Reserve tightening monetary policy.The Nasdaq ended down 10.7% from its Nov. 19 closing record high, as stocks sold off into the market close. A correction is confirmed when an index closes 10% or more below its record closing level.The Nasdaq's last correction was in early 2021, when the tech-heavy index fell more than 10% from Feb. 12 to March 8. It was the fourth time in the two yearssince the coronavirus pandemic shook global markets that the index has found itself in a correction.On Wednesday, Apple shares fell 2.1%, weighing most on the Nasdaq, while declines in Tesla and Amazon also dragged on the index.Stocks have gotten off to a rocky start in 2022, as a fast rise in Treasury yields amid concerns the Fed will become aggressive in controlling inflation has particularly hit tech and growth shares. The benchmark S&P 500 is down about 5% so far this year.“Any beginning of tightening often results in significant volatility and I think there is always that risk that there is a policy error and it ends the economic cycle,\" said Kristina Hooper, chief global market strategist at Invesco. \"So we just have a lot of apprehension.”The Dow Jones Industrial Average fell 339.82 points, or 0.96%, to 35,028.65, the S&P 500 lost 44.35 points, or 0.97%, to 4,532.76 and the Nasdaq Composite dropped 166.64 points, or 1.15%, to 14,340.26.Consumer discretionary fell most among S&P 500 sectors, dropping 1.8%, while financials dropped about 1.7% and technology slid 1.4%.The small-cap Russell 2000 fell 1.6%.Stocks had tumbled on Tuesday, with the Nasdaq falling 2.6%, after weak results from Goldman Sachs and a spike in Treasury yields. U.S. Treasury yields eased on Wednesday from two-year highs.Investors are looking to next week's Fed policy meeting for more clarity on central bankers' plans to rein in inflation. Data last week showed U.S. consumer prices increased solidly in December, culminating in the largest annual rise in inflation in nearly four decades.\"There's a fair amount of anxiety in terms of how the next three to six months are going to play out with a rate-hike cycle set to start likely in March,\" said Michael James, managing director of equity trading at Wedbush Securities in Los Angeles.In company news, shares of Procter & Gamble rose 3.4% after the consumer goods company bumped up its annual sales forecast.$Bank of America Corp(BAC-N)$ reported a better-than-expected 30% jump in quarterly profit, while Morgan Stanley also reported fourth-quarter profit which beat market expectations, following uneven results from other banks. Bank of America shares rose 0.4%, while Morgan Stanley shares gained 1.8%.Declining issues outnumbered advancing ones on the NYSE by a 2.06-to-1 ratio; on Nasdaq, a 2.09-to-1 ratio favored decliners.The S&P 500 posted 13 new 52-week highs and seven new lows; the Nasdaq Composite recorded 23 new highs and 630 new lows.About 11.4 billion shares changed hands in U.S. exchanges, compared with the 10 billion daily average over the last 20 sessions.Nasdaq confirms fourth correction since pandemic hit.","news_type":1,"symbols_score_info":{".IXIC":0.9,".SPX":0.9,".DJI":0.9,"NQmain":1}},"isVote":1,"tweetType":1,"viewCount":2941,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9005484481,"gmtCreate":1642382337230,"gmtModify":1676533706157,"author":{"id":"4091976027440070","authorId":"4091976027440070","name":"NeM0ooo","avatar":"https://static.tigerbbs.com/fc945b6e362666c4cb11d3c9b09018e8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091976027440070","idStr":"4091976027440070"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9005484481","repostId":"1102620537","repostType":4,"isVote":1,"tweetType":1,"viewCount":3965,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9005485540,"gmtCreate":1642382257536,"gmtModify":1676533706140,"author":{"id":"4091976027440070","authorId":"4091976027440070","name":"NeM0ooo","avatar":"https://static.tigerbbs.com/fc945b6e362666c4cb11d3c9b09018e8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091976027440070","idStr":"4091976027440070"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9005485540","repostId":"1102620537","repostType":4,"isVote":1,"tweetType":1,"viewCount":4538,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9005859416,"gmtCreate":1642248302260,"gmtModify":1676533695592,"author":{"id":"4091976027440070","authorId":"4091976027440070","name":"NeM0ooo","avatar":"https://static.tigerbbs.com/fc945b6e362666c4cb11d3c9b09018e8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091976027440070","idStr":"4091976027440070"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9005859416","repostId":"1167122618","repostType":4,"repost":{"id":"1167122618","kind":"news","pubTimestamp":1642212214,"share":"https://ttm.financial/m/news/1167122618?lang=en_US&edition=fundamental","pubTime":"2022-01-15 10:03","market":"us","language":"en","title":"Morgan Stanley Promotes Biggest Class of Managing Directors Since 2012","url":"https://stock-news.laohu8.com/highlight/detail?id=1167122618","media":"Seeking Alpha","summary":"While efforts to hire and retain workers pick up across Wall Street, Morgan Stanley(NYSE:MS)names 19","content":"<html><head></head><body><ul><li>While efforts to hire and retain workers pick up across Wall Street, Morgan Stanley(NYSE:MS)names 199 employees as new managing directors, a person with knowledge on the matter told Bloomberg.</li><li>This is up from 171 last year and 130 in 2020, Bloomberg reports. The U.S. region counts for 64% of the promotions, with 23% in Europe, the Middle East and Africa, and 14% in Asia.</li><li>A third of the new managing directors are women, the person told Bloomberg. This means 23% of the bank's managing directors are female, a new record, Bloomberg notes.</li><li>Recall Goldman Sachs(NYSE:GS)recently said it plans to boost hiring in Latin America after a record year.</li><li>Previously, (Jan. 4, 2021) Morgan Stanley inked a lease for BlackRock'sheadquarters in New York City.</li></ul></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Morgan Stanley Promotes Biggest Class of Managing Directors Since 2012</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMorgan Stanley Promotes Biggest Class of Managing Directors Since 2012\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-15 10:03 GMT+8 <a href=https://seekingalpha.com/news/3788415-morgan-stanley-promotes-most-staff-to-managing-directors-since-2012-bloomberg><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>While efforts to hire and retain workers pick up across Wall Street, Morgan Stanley(NYSE:MS)names 199 employees as new managing directors, a person with knowledge on the matter told Bloomberg.This is ...</p>\n\n<a href=\"https://seekingalpha.com/news/3788415-morgan-stanley-promotes-most-staff-to-managing-directors-since-2012-bloomberg\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MS":"摩根士丹利"},"source_url":"https://seekingalpha.com/news/3788415-morgan-stanley-promotes-most-staff-to-managing-directors-since-2012-bloomberg","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167122618","content_text":"While efforts to hire and retain workers pick up across Wall Street, Morgan Stanley(NYSE:MS)names 199 employees as new managing directors, a person with knowledge on the matter told Bloomberg.This is up from 171 last year and 130 in 2020, Bloomberg reports. The U.S. region counts for 64% of the promotions, with 23% in Europe, the Middle East and Africa, and 14% in Asia.A third of the new managing directors are women, the person told Bloomberg. This means 23% of the bank's managing directors are female, a new record, Bloomberg notes.Recall Goldman Sachs(NYSE:GS)recently said it plans to boost hiring in Latin America after a record year.Previously, (Jan. 4, 2021) Morgan Stanley inked a lease for BlackRock'sheadquarters in New York City.","news_type":1,"symbols_score_info":{"MS":0.9}},"isVote":1,"tweetType":1,"viewCount":4135,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9005950385,"gmtCreate":1642152555619,"gmtModify":1676533686923,"author":{"id":"4091976027440070","authorId":"4091976027440070","name":"NeM0ooo","avatar":"https://static.tigerbbs.com/fc945b6e362666c4cb11d3c9b09018e8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091976027440070","idStr":"4091976027440070"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9005950385","repostId":"1194577805","repostType":4,"repost":{"id":"1194577805","kind":"news","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1642151423,"share":"https://ttm.financial/m/news/1194577805?lang=en_US&edition=fundamental","pubTime":"2022-01-14 17:10","market":"us","language":"en","title":"J&J booster 85% effective against hospitalisation by Omicron for 1-2 months -S.African study","url":"https://stock-news.laohu8.com/highlight/detail?id=1194577805","media":"Reuters","summary":"JOHANNESBURG, Jan 14 (Reuters) - A Johnson and Johnson COVID-19 vaccine booster shot is 85% effectiv","content":"<html><head></head><body><p>JOHANNESBURG, Jan 14 (Reuters) - A Johnson and Johnson COVID-19 vaccine booster shot is 85% effective in protecting against being hospitalised by the Omicron variant for 1-2 months after it is received, the head of South Africa's Medical Research Council (SAMRC) said on Friday.</p><p>Glenda Grey presented the findings of a SAMRC study at a South African health ministry briefing on the COVID-19 fourth wave, which has been driven by the new variant.</p><p>"We saw an 85% vaccine effectiveness and we saw that this kind of vaccine effectiveness is maintained for up to two months," she said. We are very happy to report very high levels of vaccine effectiveness against Omicron."</p><p>The study looked at hospitalisations of healthcare workers infected with during the fourth wave, and found that the booster shot reduced hospitalisations by 63% in the first two weeks after the booster, going up to 85% after that for between one and two months.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>J&J booster 85% effective against hospitalisation by Omicron for 1-2 months -S.African study</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJ&J booster 85% effective against hospitalisation by Omicron for 1-2 months -S.African study\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2022-01-14 17:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>JOHANNESBURG, Jan 14 (Reuters) - A Johnson and Johnson COVID-19 vaccine booster shot is 85% effective in protecting against being hospitalised by the Omicron variant for 1-2 months after it is received, the head of South Africa's Medical Research Council (SAMRC) said on Friday.</p><p>Glenda Grey presented the findings of a SAMRC study at a South African health ministry briefing on the COVID-19 fourth wave, which has been driven by the new variant.</p><p>"We saw an 85% vaccine effectiveness and we saw that this kind of vaccine effectiveness is maintained for up to two months," she said. We are very happy to report very high levels of vaccine effectiveness against Omicron."</p><p>The study looked at hospitalisations of healthcare workers infected with during the fourth wave, and found that the booster shot reduced hospitalisations by 63% in the first two weeks after the booster, going up to 85% after that for between one and two months.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1194577805","content_text":"JOHANNESBURG, Jan 14 (Reuters) - A Johnson and Johnson COVID-19 vaccine booster shot is 85% effective in protecting against being hospitalised by the Omicron variant for 1-2 months after it is received, the head of South Africa's Medical Research Council (SAMRC) said on Friday.Glenda Grey presented the findings of a SAMRC study at a South African health ministry briefing on the COVID-19 fourth wave, which has been driven by the new variant.\"We saw an 85% vaccine effectiveness and we saw that this kind of vaccine effectiveness is maintained for up to two months,\" she said. We are very happy to report very high levels of vaccine effectiveness against Omicron.\"The study looked at hospitalisations of healthcare workers infected with during the fourth wave, and found that the booster shot reduced hospitalisations by 63% in the first two weeks after the booster, going up to 85% after that for between one and two months.","news_type":1,"symbols_score_info":{"JNJ":0.9}},"isVote":1,"tweetType":1,"viewCount":4177,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9002579368,"gmtCreate":1642052222545,"gmtModify":1676533676288,"author":{"id":"4091976027440070","authorId":"4091976027440070","name":"NeM0ooo","avatar":"https://static.tigerbbs.com/fc945b6e362666c4cb11d3c9b09018e8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091976027440070","idStr":"4091976027440070"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9002579368","repostId":"1144288118","repostType":4,"repost":{"id":"1144288118","kind":"news","pubTimestamp":1642051328,"share":"https://ttm.financial/m/news/1144288118?lang=en_US&edition=fundamental","pubTime":"2022-01-13 13:22","market":"us","language":"en","title":"Novavax Stock Still Has A Solid Chance","url":"https://stock-news.laohu8.com/highlight/detail?id=1144288118","media":"InvestorPlace","summary":"The Covid-19 pandemic has worked in the favor of pharmaceutical companies. Many have become hot pick","content":"<div>\n<p>The Covid-19 pandemic has worked in the favor of pharmaceutical companies. Many have become hot picks today. Although Novavax(NASDAQ:NVAX) hasn’t had a smooth ride lately, there is a lot to look ...</p>\n\n<a href=\"https://investorplace.com/2022/01/nvax-stock-still-has-a-solid-chance-at-being-a-vaccine-race-winner/\">Source Link</a>\n\n</div>\n","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax Stock Still Has A Solid Chance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax Stock Still Has A Solid Chance\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-13 13:22 GMT+8 <a href=https://investorplace.com/2022/01/nvax-stock-still-has-a-solid-chance-at-being-a-vaccine-race-winner/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Covid-19 pandemic has worked in the favor of pharmaceutical companies. Many have become hot picks today. Although Novavax(NASDAQ:NVAX) hasn’t had a smooth ride lately, there is a lot to look ...</p>\n\n<a href=\"https://investorplace.com/2022/01/nvax-stock-still-has-a-solid-chance-at-being-a-vaccine-race-winner/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://investorplace.com/2022/01/nvax-stock-still-has-a-solid-chance-at-being-a-vaccine-race-winner/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1144288118","content_text":"The Covid-19 pandemic has worked in the favor of pharmaceutical companies. Many have become hot picks today. Although Novavax(NASDAQ:NVAX) hasn’t had a smooth ride lately, there is a lot to look forward to. Investors tend to think that the current surge in Covid-19 cases across the globe could mean an end of the pandemic shortly but this may not be the case. Despite the dip in NVAX stock in 2021, it could have a stellar 2022.The stock has dipped significantly over the past six months and is currently trading much lower than its all-time high. There haven’t been any major company announcements or significant events that could’ve led to this decline in the price. Therefore, it stems from investors’ lack of enthusiasm towards the company’s prospects.This might change in 2022. NVAX stock is trading at $130 and could inch closer to $150 soon.Here are two reasons I think the stock will move upwards.Vaccine Demand Could ExplodeDespite the rise in coronavirus cases across the globe, the cases are milder and the hospitalization rates are lower. The good news is that it could lead to lower deaths and a higher recovery rate.However, this does not change the vaccine scenario. The demand for vaccines is not going to decline anytime soon and if the current surge continues, we could see a rise in demand.Once an early favorite, Novavax took too long to file for Emergency Use Authorization (EUA) in the U.S. due to manufacturing and technical issues. This in turn led to the consistent dip in the stock throughout 2021.Since the Food and Drug Administration (FDA) allows the mixing of vaccines, there will still be a demand for Novavax as a booster. It could give a huge lift to the company and will allow it to gain a larger market share.The demand for vaccines will be a key factor for the company. If it can meet the demands by increasing the manufacturing capacity, it will be able to generate massive revenue.On these metrics alone, NVAX stock could be a winner this year.It is also important to keep in mind that the company only recently got authorizations from different countries and this will reflect in the bottom line for the next quarter.Novavax Is Getting Approvals From Different CountriesNovavax already has authorization in 31 countries and this is no small feat.The company is working towards supplying more than200 million doses to EU countries alone. They expect a European Union EUA for their vaccine in the next few months which could take the stock higher.Thanks to these international authorizations, Novavax does not depend on any single country, like the United States, for revenue. It can manage to generate solid revenue by providing vaccines to developing countries and the European Union. The first-quarter numbers will be important for the investors as they will speak about the production capacity and the deliveries of the vaccine.Novavax’s vaccine data is positive. And if it manages to roll out the vaccines on time, NVAX stock will go even higher.The Bottom Line On NVAX StockThe next quarter for the company could be huge and it could start generating strong revenue very soon.There is always a risk when a stock is heavily dependant on a single product but if the company manages to move at the right time and gets the authorization, it could beat analyst projections.NVAX stock is trading at a discount currently and the coming quarter could take it to a new high.If the pandemic becomes endemic in the near future, we will regularly need vaccines and this is when Novavax will finally be a winner in the vaccine race.","news_type":1,"symbols_score_info":{"NVAX":0.9}},"isVote":1,"tweetType":1,"viewCount":2513,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9002860341,"gmtCreate":1641963911091,"gmtModify":1676533667250,"author":{"id":"4091976027440070","authorId":"4091976027440070","name":"NeM0ooo","avatar":"https://static.tigerbbs.com/fc945b6e362666c4cb11d3c9b09018e8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091976027440070","idStr":"4091976027440070"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9002860341","repostId":"2202735009","repostType":4,"isVote":1,"tweetType":1,"viewCount":3038,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":true}